PicoSearch  
     
CaringBridgeGoodSearch

NPC Research Updates - National Institutes of Health (NIH)

**UPDATE**

National Institutes of Health ~ Cyclodextrin Therapy Trial

A message from Dr. Denny Porter at NIH:

[Here is] an update on the TRND FDA meeting held this past Tuesday.  We still have a lot of hard work to do, but the meeting was positive.  I am including a picture of the TRND Team that participated in this meeting.  It is an impressive collection of expertise and this group has greatly facilitated moving the effort to develop a safe and effective therapy for NPC forward.  We know the photo is missing one critical facet of the team - the families.

Thank you for your support.

Denny, Nicole and Nuria
Forbes D. Porter, MD, PhD; Senior Investigator, PDGEN, NICHD
Acting Program Director, PDGEN, NICHD; Clinical Director, NICHD

 Follow this link to read the November 4th, 2011, announcement: Cyclodextrin Trial Update 11-4-11

NPC Team TRND FDA Nov 1 2011

     Members of the NPC Team.  Photo taken on Nov 1, 2011, at an update meeting with the FDA.

[Nov.4, 2011 nmh]


Doctor with child and its mother

NPC Research Updates
Informational Conference Call/Webinar
Monday, May 2, 2011
4:00 pm Central Time (5:00 pm Eastern; 2:00 pm Pacific)

Thank you to all who took part in the NNPDF Niemann-Pick Type C Research Updates conference call/Webinar on May 2nd. We especially appreciate the time and expertise that Drs. Ory, Porter, Patterson and Austin lend to the NNPDF and our NPC families.

If you have any questions about the material presented, please e-mail them to: nnpdf@nnpdf.org.  We will work to gather the answers and will then post them on this page.

Text document of the conference call/Webinar as a PDF

The recorded conference call/Webinar is now available (for 30 days) for those who were not able to participate, or for those who participated and would like to review the information presented.  Instructions appear below. 

If you have difficulty accessing the Webinar, please contact us!  We want to be certain that everyone interested has the opportunity to hear the information presented.

NOTES:  The recording is available for 30 days only. Also, due to initial technical difficulties, the actual meeting content begins a little more than 12 minutes into the recording.  You will be able to skip through the first 12 minutes of the recording and advance to the actual start of the meeting. The full recording is approximately 74 minutes in length, including those first 12 minutes.

Two ways to access the meeting:

1) Online (with video and audio)
First, run this playback test http://nnpdfniemannpickdisease.pgimeet.com/Utilities/playbackTest.aspx to determine if your computer has the appropriate player. If your computer does not have the GlobalMeet Conference player, you will be offered a link to download the player.

Once you have the player on your computer, click this link and follow the instructions in the lefthand column to download the Webinar. Once the Webinar recording opens, you can use the slider near the middle left of the screen to advance the recording to 12 minutes in.

2) Via telephone (audio only)
Dial the appropriate number from the list below.  When prompted, enter the passcode. 

Replay Dial-In Numbers and Passcode

North America Toll Free:  1-888-203-1112
Toll:                         1-719-457-0820
Toronto Toll:               1-647-436-0148

Replay Passcode:  77405148

Once the audio begins to play, you may: 
Press 5 to return to the beginning of the recording
Press 7 to back up the recording 30 seconds
Press 8 to pause the recording
Press 9 to advance the recording by 30 seconds (use this feature to get to the 12-minute starting point).

 

If you have a question for the presenters regarding the information on the recording, please submit it to the NNPDF Central Office and we will work to obtain the answers for you.

If you have difficulty accessing the Webinar, please contact us!  We want to be certain that everyone interested has the opportunity to hear the information presented.

The National Institutes of Health (NIH), in collaboration with the Therapeutics for Rare and Neglected Diseases Program (TRND),  is developing a clinical trial utilizing cyclodextrin for Niemann-Pick Type C  patients.

The clinical trial is in the planning phase and many criteria must be met and numerous approvals granted before the trial can take place. Dr. Forbes "Denny" Porter, a Senior Investigator at the NIH, and Dr. Daniel Ory, NNPDF Scientific Advisory Board Chair, are working collaboratively to bring this trial to our NPC patient community.

SAVE THE DATE - CONFERENCE CALL
On Monday, May 2, 2011, the NNPDF will host a conference call/Webinar with key constituents and researchers, for all interested parties in the NPC community to learn more about the work being done at the NIH.  The call will begin at 4:00 pm Central Time (5:00 pm Eastern; 2:00 pm Pacific).

Presenters/NPC experts expected to participate in the call include:  Dr. Forbes "Denny" Porter of NIH, Dr. Daniel Ory of Washington University, Dr. Christopher P. Austin of TRND, and Dr. Marc Patterson of Mayo Clinic.

Conference Call Agenda
Agenda topics for the conference call are expected to include:  NPC Observational Study at the NIH; development of NPC biomarkers; the NAC trial; use of a blood test for NPC diagnosis; and the current effort at TRND/NIH toward developing plans for a cyclodextrin trial at NIH. 

Updates at the 2011 NNPDF Family Support and Medical Conference
Following the conference call, further updates on the clinical trial will be presented at the NNPDF Family Support and Medical Conference in Norfolk, Virginia, July 28th - 31st.  Dr. Porter and Dr. Ory will answer questions pertaining to the clinical trial and will give updates about the trial at the conference.  Registration packets for the Family Conference will be mailed out to NNPDF members in May.  In the meantime, visit our Family Conference page for more information about the conference.


Instructions for Participants
(Instructions as a PDF)

On Monday, May 2, 2011, the NNPDF will host a conference call/Webinar (online meeting) with key constituents and researchers, for all interested parties in the Niemann-Pick Disease Type C (NPC) community to learn more about the work being done at the NIH.  Parents and extended family members, clinicians, researchers, caregivers, educators, and anyone with an interest in NPC is invited to participate.

Agenda topics for the conference call/Webinar are expected to include:  NPC Observational Study at the NIH; development of NPC biomarkers; the NAC trial; use of a blood test for NPC diagnosis; and the current effort at TRND/NIH toward developing plans for a cyclodextrin trial at NIH.  Presenters/experts we expect will participate include:  Dr. Forbes “Denny” Porter, Dr. Daniel Ory, Dr. Marc Patterson, and Dr. Christopher Austin.

This meeting will begin at 4:00 pm Central Time (5:00 pm Eastern, 2:00 pm Pacific).  International participants are invited, as well.

The meeting will be held using GlobalMeet’s “PGiMeet” interface.  Participants will need access to a telephone for the audio portion of the call, as well as a computer to log in to a Web page to see any documents and graphics.  Therefore, Internet access as well as access to a telephone will be required for full participation.   (Those without access to a computer may participate in the audio portion only – see separate instructions below.)

Test Your System
First-time PGi users -- Run the System Test at any time prior to the meeting to determine if your computer equipment and internet connection are sufficient to support the Webinar. 

Click this link to run the test: http://nnpdfniemannpickdisease.pgimeet.com/utilities/fullbrowsertest.aspx

Web and Audio Access (preferred method for full participation)

Steps for participants (from any location around the world) who will join the meeting via the Web page (for graphics) and telephone (audio). 

Accessing the meeting through this method is free and should not result in long-distance charges to your telephone bill.

About 5 minutes prior to the meeting:

 (Enable pop-ups if you are prompted to do so.) 

Audio Access Only

Please note:
  This option is offered for those who may not have access to a computer.  Accessing the meeting this way may incur long distance call charges to your telephone bill (including international charges), depending on your service plan.  Use of the Audio Access Only option will not allow the participant to view any documents or graphics used by the presenters.  Attendees using the Audio Access Only option will not be able to submit questions to the presenters, as all audio lines (except the presenters’ lines) will be muted.

Steps for participants who will join the meeting via telephone (audio) only.

About 5 minutes prior to the meeting:

From the U.S. and Canada:  Dial 1-719-387-4105
(For countries other than the U.S. or Canada, see the list of dial-in access numbers below.)

The call will be answered by an automated attendant, who will instruct you to enter your “Passcode” (276192), followed by the # sign.  You will then be asked to say your name, followed by the # sign.  You will then hear music until the meeting begins, or you may hear the voices of the presenters if the meeting line is already open.

NOTE:  Using the “Audio Access Only” method to participate in the meeting (dialing into the meeting instead of having the system call you) will result in charges to your telephone bill.  These charges may be quite large, as the meeting is expected to last at least an hour, and international rates will apply.  Please do not use any toll-free numbers to call in, as the charges to the NNPDF are exorbitant.   We recommend that you try to use the Web and Audio Access method detailed above, if at all possible, instead. 

Dial-in access numbers for participants in countries other than the U.S. or Canada:

Australia, Melbourne: +61 (0) 3 8687 0519

Australia, Sydney: +61 (0) 2 9009 0646

Austria, Vienna: +43 (0) 1 25301 0158

Bahrain, Manama: +973 1619 9397

Belgium, Brussels: +32 2 789 2131

Bulgaria, Sofia: +359 (0) 2 491 7543

Canada, Montreal: +1 514 315 3156

Czech Republic, Prague: +420 246 019 649

Denmark, Copenhagen: +45 32 71 16 38

Estonia, Tallinn: +372 698 7460

Finland, Helsinki: +358 (0) 9 2310 1673

France, Paris: +33 (0) 1 70 37 14 53

Germany, Frankfurt: +49 (0) 69 66777 5742

Germany, Munich: +49 (0) 89 7104 24677

Greece, Athens: +30 211 181 3802

Hong Kong: +852 3071 2998

Hungary, Budapest: +36 1778 9073

Ireland, Dublin: +353 (0) 1 5530138

Israel, Tel Aviv: +972 3763 0677

Italy, Milan: +39 02 304 648 21

Italy, Rome: +39 06 452 366 17

Japan, Chiba: +81 (0) 43 321 6777

Japan, Fukuoka: +81 (0) 92 290 6777

Japan, Hiroshima: +81 (0) 82 558 6777

Japan, Kanagawa: +81 (0) 45 677 6777

Japan, Nagoya: +81 (0) 52 850 6777

Japan, Osaka: +81 (0) 6 6123 6777

Japan, Sapporo: +81 (0) 11 234 6777

Japan, Sendai: +81 (0) 22 708 6777

Japan, Shizuoka: +81 (0) 54 902 6777

Japan, Tachikawa: +81 (0) 42 841 6777

Japan, Tokyo: +81 (0) 3 4455 1117

Japan, Toyama: +81 (0) 76 408 6777

Japan, Urawa: +81 (0) 48 698 6777

Latvia, Riga: +371 6778 2551

Lithuania, Vilnius: +370 5205 5160

Luxembourg: +352 2088 0607

Mexico, Mexico City: +52 55 1207 7357

Netherlands, Amsterdam: +31 (0) 20 708 5037

New Zealand, Auckland: +64 (0) 9 358 4010

Norway, Oslo: +47 21 00 26 24

Poland, Warsaw: +48 (0) 22 212 06 50

Portugal, Lisbon: +351 2141 59167

Romania, Bucharest: +40 (0) 31 810 7451

Russia, Moscow: +7 495 213 17 59

Singapore: +65 3158 1054

Slovakia, Bratislava: +421 2 3345 6502

Slovenia, Ljubljana: +386 1600 9374

South Africa,Johannesberg : +27 11 019 7033

South Korea, Seoul: +82 (0) 2 3483 1330

Spain, Barcelona: +34 93 545 2562

Spain, Madrid: +34 91 791 7468

Sweden, Stockholm: +46 (0) 8 5051 4933

Switzerland, Geneva: +41 (0) 22 592 7956

Switzerland, Zurich: +41 (0) 43 456 9233

UK, Belfast: +44 (0) 28 9595 0015

UK, Edinburgh: +44 (0) 13 1460 1110

UK, London: +44 (0) 203 059 5712

UK, Reading: +44 (0) 11 8370 1110

Instructions as a PDF

[Apr 28, 2011 mem]

“The National Niemann-Pick Disease Foundation (NNPDF) does not engage in the practice of medicine. It is not a medical authority nor does it claim to have medical knowledge. This site is an educational service of the National Niemann-Pick Disease Foundation and is not meant to provide diagnostic or treatment advice. Information contained or suggested on this Web site does not constitute medical advice. For all information related to care, medication or treatment, the NNPDF recommends consulting a physician to determine if information presented is applicable. Please review these additional cautions about medical information provided on the Internet.”